A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty
Clinical trial NCT00269906 · COMPLETED
Trial details
- NCT number
- NCT00269906
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1993-05-01
- Primary completion
- 1995-12-01
- Enrollment
- 1265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.